CCMI
PTCT icon

Creative Capital Management Investments’s PTC Therapeutics PTCT Stock Holding History

Creative Capital Management Investments’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14K Buy
+14
New +$1.01K ﹤0.01% 1063

Other funds holding PTCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Creative Capital Management Investments's PTCT Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 14 shares worth $1.14K. The stake represents ﹤0.01% of the portfolio and ranks #1063 among its holdings.

69 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Creative Capital Management Investments held 14 shares of PTC Therapeutics worth $1.14K as of Q2 2026.
  • PTC Therapeutics was a new Creative Capital Management Investments position in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1063 holding.
  • 69 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.